to evaluate the effect of yashtimadhu amlaki churna in hairfall and to compare the mode of administration of yashtimadhukadi tail on hairfall through scalp and through nasal route.

Phase 1/2

Not yet recruiting

• Conditions: Khalitya (Hairfall)

• Registration Number: CTRI/2017/04/008441
• Lead Sponsor: National Institute of Ayurveda Jaipur

Brief Summary

A comparative clinical trial to evaluate the efficacy of yashtimadhu amlaki churna in khalitya w.s.r to hairfall will be conducted. 60 patients will be selected randomly from Arogyashala OPD & IPD, National Institute of  Ayurveda, Jaipur which will be well diagnosed having Khalitya (hairfall) as per the signs and symptoms described in Ayurvedic classical text. Duration of administration of oral drug will be 60 days. Yashtimadhu churna 4 gms and amlaki churna 6 gms will be given in two divided doses per day to the patients. All the participants will be divided into two groups. Group A will be given the above mentioned oral drug along with the nasya of yashtimadhukadi tail for 7 days. Group B will be given the above mentioned oral drug along with the shiro abhyanga of yashtimadhukadi tail for 30 days. Follow up will be done at 15, 30, 45 and 60 days after the completion of the trial. Written informed consent will be obtained. No economical aid will be given to the patient during the trial. ADR, if any will be recorded in the prescribed format and reported to RPVC, NIA, Jaipur. ADR, if any will be managed and / or referred suitably.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2017-04-27
• Study Start: 2017-05-15

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• 1)Patients who have classical signs and symptoms of khalitya since one month or more.
• 2)Patients within age group of 20 to 40 years of either sex.

Exclusion Criteria

• 1)Patients below 20 years and above 40 years.
• 2)Patients who have diseases like Alopecia totalis, Tinea capitis, folliculisis devaculans and in Ayurvediya terms patients of Arunshika, Indralupta.
• 3)Patient suffering from any systemic diseases.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is expected that trial drug will exert a significant action over hairfall with other associated symptoms.	15 months

Secondary Outcome Measures

Name	Time	Method
Significant reduction in the hairfall (through the procedure and the oral drug) will increase quality of life, self conidence and self esteem of the person with total gain of mental, physical and spiritual health.	60 days

Trial Locations

Locations (1)

Arogyashala, National Institute of Ayurveda Jaipur; 🇮🇳 Jaipur, RAJASTHAN, India

Arogyashala, National Institute of Ayurveda Jaipur

🇮🇳Jaipur, RAJASTHAN, India

Parul Anand

Principal investigator

09086081993

anand.parul.mailbox@gmail.com